Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Marais

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Human Molecular Genetics|September 15, 1999
Mutation -59c-->t in repeat 2 of the LDL receptor promoter: reduction in transcriptional activity and possible allelic interaction in a South African family with familial hypercholesterolaemiaC L Scholtz, A V Peeters, C F Hoogendijk, et al.
Clinical Genetics|January 11, 2018
Identification of a single MPV17 nonsense-associated altered splice variant in 24 South African infants with mitochondrial neurohepatopathyS Meldau, R J De Lacy, G T M Riordan, et al.
The Journal of Clinical Investigation|June 1, 1991
Amino acid substitution (Ile194----Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric originH E Henderson, Y Ma, M F Hassan, et al.
Journal of Lipid Research|June 4, 1998
HMG-CoA reductase is not the site of the primary defect in phytosterolemiaG M Berger, R J Pegoraro, S B Patel, et al.
Atherosclerosis|June 17, 2000
Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemiaF J Raal, A S Pappu, D R Illingworth, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 1, 1991
A 6-month trial of simvastatin (HMG-CoA reductase inhibitor) in the treatment of hypercholesterolaemiaK Steyn, H F Weich, W J Vermaak, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 16, 2019
Extensively hydrolysed infant formulas: Need for aligned definition of peptide size characteristics and standardisation of analytical methodsS Nutten, M Kuslys, F Maynard, et al.
The Journal of Clinical Investigation|September 1, 1994
Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriersP de Knijff, A M van den Maagdenberg, D I Boomsma, et al.
Journal of Lipid Research|April 1, 2000
Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosisS M Clee, N Bissada, F Miao, et al.
Atherosclerosis|July 11, 2009
Efficacy criteria and cholesterol targets for LDL apheresisGilbert R Thompson, M Barbir, D Davies, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Human Molecular Genetics|September 15, 1999
Mutation -59c-->t in repeat 2 of the LDL receptor promoter: reduction in transcriptional activity and possible allelic interaction in a South African family with familial hypercholesterolaemiaC L Scholtz, A V Peeters, C F Hoogendijk, et al.
Clinical Genetics|January 11, 2018
Identification of a single MPV17 nonsense-associated altered splice variant in 24 South African infants with mitochondrial neurohepatopathyS Meldau, R J De Lacy, G T M Riordan, et al.
The Journal of Clinical Investigation|June 1, 1991
Amino acid substitution (Ile194----Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric originH E Henderson, Y Ma, M F Hassan, et al.
Journal of Lipid Research|June 4, 1998
HMG-CoA reductase is not the site of the primary defect in phytosterolemiaG M Berger, R J Pegoraro, S B Patel, et al.
Atherosclerosis|June 17, 2000
Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemiaF J Raal, A S Pappu, D R Illingworth, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 1, 1991
A 6-month trial of simvastatin (HMG-CoA reductase inhibitor) in the treatment of hypercholesterolaemiaK Steyn, H F Weich, W J Vermaak, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 16, 2019
Extensively hydrolysed infant formulas: Need for aligned definition of peptide size characteristics and standardisation of analytical methodsS Nutten, M Kuslys, F Maynard, et al.
The Journal of Clinical Investigation|September 1, 1994
Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriersP de Knijff, A M van den Maagdenberg, D I Boomsma, et al.
Journal of Lipid Research|April 1, 2000
Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosisS M Clee, N Bissada, F Miao, et al.
Atherosclerosis|July 11, 2009
Efficacy criteria and cholesterol targets for LDL apheresisGilbert R Thompson, M Barbir, D Davies, et al.
Pageof 11